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As a fertilized egg begins its journey of embryonic development it carries 46 chromosomes within its nucleus. The chromosomes are arranged in 23 pairs; one chromosome of every pair is
from a parent. These chromosomes are made up of DNA
molecules (geoxyribonucleic gcid). The chromosomal DNA
material is a string of informational segments known as genes.
Genes carry the instructions to make proteins. Proteins are the
biofunctional building blocks oflife. The arrangement of genes
along the chromosomal molecule constitutes a genetic map.
Delving further, we can identify this genetic DNA molecule as
a set of chemical subunits, the nucleotides. The order of
nucleotides, in a certain gene, gives us the finest level of genetic
resolution, known as the DNA sequence.
The Human Genome Project will endeavor to map all
known genes to their respective chromosomes and identify the
human genome at the most refined level, the DNA sequence.
The pursuit of this genetic knowledge and the resulting revelations will expand the parameters of the scientific understanding
of life far beyond the scope known today. When the DNA
sequence of the entire human genome is deciphered, the
nucleotide makeup of all now -known genes as well as unknown
genes will be identified. This refined basis of identification
allows us to explore life and self at a heightened new level.
Perceived objectively, DNA sequencing of the human genome
provides us with an improved "fingerprint" of each human. As
the now-common fingerprint aids in uniquely identifying different humans, so will the genetic fingerprint identify them at a.
molecular level.
This form of exploration is not entirely new to science, as the

entire genomic sequences of many viruses are known today. In
addition, many other subhuman life forms (such as bacteria,
fungi and protozoa) are being similarly studied. Knowing the
genomic DNA seq uence of many viruses has helped define their
modes of action and thus aided in the development of defense
mechanisms against infection. Such discoveries bred the realization of the potential preventive treatment of genetically based
maladies.
Gene therapy is a fast-developing technological approach
with major medical implications. The maturation of the field of
human gene therapy relies heavily on genetic knowledge of the
factors involved in the practice. Hence, the Human Genome
Project and the advancement of human gene therapy are closely
linked, each helping to advance the other.
In most cases, genes convey information for making proteins,
which in turn undertake different functions in each cell. When
a protein is absent or malfunctions in a cell, it triggers a detectable
biological change that is generally interpreted as an aberrancy. If
the absent or abnormal behavior of the protein is backtracked to
a change at a single gene, it would be possible to correct the
detectable aberrancy by simply replacing or complementing the
defective gene's DNA sequence with a "healthy" version. This
possibility has now become reality through the work of pioneers
such as Dr. French Anderson. Dr. Anderson and colleagues have
successfully complemented the biofunctional deficiency of the
enzyme adenosine deaminase (ADA) [which leads to a form of
severe combined immunodeficiency (SCI D) and is a product of
a single gene]. They used a retroviral delivery system to
introduce a correct copy of the ADA gene into deficient patients.
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This mode of treatment is transient and has not thus far shown
any adverse side effects in any treated patients. However,
treatment has to be administered periodically to maintain the
level of the cure.
Thus, although gene therapy has become a reality, it is still
limited in application to single gene mutations. Greater knowledge of the genome may allow gene therapy to expand to include
treatment of diseases resulting from multiple genetic mutations.
Knowledge about genetic predisposition to certain diseases also
is useful as a means of preventive medicine. A person who is
aware of a possible fate would likely take action to avoid it. Such
an example is seen in the hazards of breast cancer, where
predisposed persons may choose to remove potentially cancerous tissue, thus vastly improving their chances and quality oflife.
Additionally, knowing oneself at the molecular genetic level.
may increase one's life-style options.
From a different standpoint, because results from the Human Genome Project will strengthen the field of gene therapy,
in the future those considered the "surviving fittest" may
include many more who otherwise would have had to accept at
least a compromised quality of life. It must be realized that the
Human Genome Project and the development of gene therapy
are directed toward divulging basic knowledge and correcting or
preventing what is defined as compromising diseases. The
Human Genome Project may be viewed as discoveries in human
molecular anatomy. Gene therapy may be considered as corrective molecular surgery.
Because there is no existing equivalent to the knowledge
generated by the Human Genome Project, we can only imagine
the potential explosion of scientific possibilities. As the changes
come we need to be prepared to grow and modify with them.
One of the ways to avoid panic and disharmony due to scientific
knowledge is education. It is up to the pioneering scientists to
extend their teachings so that others from different walks oflife
are included in the development of a better biological understanding of humans-and consequently humanity.•
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SOIne Legal Ramifications
for Newborns
Andrea K. Scott, JD, iliA
Cooper, Brown, Kardaras & Schatf
Pasadena, California
As public debate intensifies over the merits and perils posed
by the Human Genome Project ("the Project"),thesoleconsensus
to emerge is that the Project wields power sufficient to alter the
lives of each of us and our progeny. Arising out of the Project and
resultant biotechnologies are two discrete legal causes of action
affecting the unborn and newborn infants: "wrongful birth" and
"wrongful life. " Al though q uite new, these causes of action have
interesting common law antecedents.
The first reported case in American jurisprudence to deal
with the issue of whether or not a cause of action for damages
could accrue to the unborn took place more than a century ago.
In Dietrich v. Inhabitants ofNorthampton, 1 Justice Oliver Wendell
Holmes rejected the proposition that an infant injured before it
was "born alive" could be viewed as a "person" recognized by
the law as capable of having standing or the right to present such
a claim. Holmes' difficulty in according a fetus the right to be
free from injury by a third person was based first on a lack oflegal
precedent and second on the concept that an unborn infant was
part of the mother at the time the injury occurred such that any
recoverable damages should inure to her rather than the fetus. 2
For many years thereafter, the judiciary followed Justice
Holmes' ruling for four reasons. First, no duty could be established to an unborn child who lived only as a part of the mother.
Second, it was considered too difficul.t ~or ~cience to establis? the (
required causal nexus between a phYSICIan s wrongful orneghgent
act and the injury to an unborn child. Third, the courts feared an
onslaught of spurious and extravagant claims. Fourth, the
judiciary believed that to allow such an action was tantamount to
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inviting similar claims by children against their mothers for
negligent behavior during pregnancy.3
The last half century, however, has witnessed a reversal
unprecedented in the history of American tort law as the judiciary in every state unanimously has upheld the existence of a
cause of action on behalf of infants born with permanent disabilities resulting from prenatal injuries. Even so, many questions remain unanswered. For example, courts remain divided
on whether or not a fetus must be viable at the time an injury is
sustained, although a majority of jurisdictions presently allow
recovery of specific damages such as medical bills when the
injury occurs prior to viability. A minority of jurisdictions limits
recovery of damages for prenatal injury to cases in which the
fetus is born alive. A few courts even allow a cause of action for
injury which occurs prior to conception. 4
In short, a firmly entrenched notion of American tort law is
that a physician may be held liable for negligence resulting in an
otherwise normal child being born in a damaged condition. In
contrast, "wrongful birth" refers to cases in which the parents
allege a physician's negligence deprived them of the opportunity to prevent the birth of a defective child. The physician's
liability in such cases invariably stems from negligence in genetic testing or genetic counseling. s
The doctrine of informed consent and the landmark case of
Roev. Wade, 6 together provide underpinnings for wrongful birth
actions. This is because such lawsuits are based on a negligent
deprivation of the parents' constitutionally protected right to
choose if they wish to have the defective offspring. In other
words, the parents do not allege that a physician caused their
child's abnormality, but rather that the health-care provider's
negligence denied them the information necessary to make an
informed decision about whether or not to conceive or continue
the pregnancy.
In negligent genetic testing cases, the parents generally are
aware they may be carriers of a genetic disorder or that other
circumstances such as the advancing age of the mother increase
the probability of having a defective child. Consequently, the
parents seek a health-care professional to perform genetic tests
on themselves and the fetus. It is a provider's failure to use the
applicable standard of care in performing and interpreting the
results of such tests which deprives parents of an opportunity to
avoid the birth of a defective infant. In short, the parents argue
that had they been properly advised by the provider about the
risk of the fetus' abnormality, their infant never would have been
born.7
Many other wrongful birth actions are based on allegations of
negligent genetic counseling in which parents allege the counselor failed to inform them of an increased probability of having
a deformed child or failed to inform them about reasonably
inexpensive tests which could determine if such deformities
were present in the fetus. 8 Alternative grounds for a wrongful
birth action arise from a physician's failure to diagnose a genetic
disease in the parents' first child in time to give the parents
,)pportunity to avoid producing a second child with the same
defect. 9
Much more innovative than the notion of wrongful birth is
the cause of action known as "wrongful life," which recognizes
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the claim of an impaired child rather than that of the parents.
The gravamen of a claim for wrongful life is that but for a
physician's negligence, the child would not have been born to
experience the pain, suffering and indignities he or she must
now endure. This cause of action is based on the notion that a
physician breached a duty owed directly or inuring derivatively
to a child by not informing his or her parents of the risk of
predictable abnormalities. Because the parents were thereby
deprived of information which would have convinced them to
decide against having the child, this breach of duty caused the
child's birth and resultant injury of "life in an impaired state." tO
Beginning in the late 1970s, a minority of courts allowed
claims for wrongful life, including the Supreme Courts of California, New Jersey, New York, and Washington. A majority of
jurisdictions, however, have since rejected wrongful life claims
for ethical, religious and policy reasons. Some courts, for example,
have held that allowing a wrongful life claim implies that non-life
is preferable to life in an impaired state and consequently,
constitutes an unacceptable denial of the sanctity and worth of
all human life. Similarly, some courts have ruled this tort is not
justiciable or feasibly administrable because it would require
judges to compare the harm of an impaired life with that of nonexistence when measuring damages. These courts assert such
claims should not be allowed absent legislative enactment.
Finally, a number of conservative courts have rejected wrongful
life claims because the plaintiffs were unable to establish the
fundamental elements of a standard tort claim, including a duty,
a breach of that duty and injury} 1
In California, the basis for liability in a wrongful life action is
not the severity of a birth defect but rather, its predictability and
the failure of a health-care provider to give parents the information required by them to decide if they wish to conceive or bear
a child which likely will be genetically defective. Additionally,
a number of cases reveal the judiciary's view that a wrongful life
claim should be allowed to go forward when a plaintiff child faces
costly physical problems, even though he or she conceivably
may lead a full and productive life. 12
For physicians, one of the most pressing questions is what
duty the health-care provider owes parents-who affirmatively
seek specific medical advice regarding a genetic disorder. The
general answer to this question is that a majority of courts impose
on the health-care provider a duty of reasonable care, including
an affirmative duty to disclose facts relevant to the parents'
decision to avoid (or not) the birth of a genetically defective
child. Some courts base this duty to disclose on a theory that
because of the physician/patient relationship a doctor has a duty
to advise the patient in accordance with correct medical practice.13 Other courts base this affirmative duty to disclose on a
theory that parents have a right not to have a defective child and
consequently, physicians have a duty to assist parents in exercising that right. 14
Finally, we come full circle in returning to a fear enunciated
by Justice Holmes that to grant a plaintiff's claim in tort for
prenatal injuries might pave the way for a cause of action by a
child against the mother for negligent behavior during pregnancy. In point of fact, no court in the United States has allowed
a child to assert a wrongful life claim against his or her parents.

3

The California legislature recently enacted a statute l :; expressly
prohibiting this type of suit.
In attempting to work within the shifting parameters of this
nascent field oflaw, one must keep in mind the fact that like the
practice of medicine, the law evolves. Inherent in the growth
process is initiative, reaction and reformulation. While societal
forces tend to encourage broad acceptance of advancements in
biotechnology, the law-by definition a conservative animalmoves forward in modest increments. In order to serve the
interests of all people in negotiating the marvels, blessings and
dangers presented by the Human Genome Project, the law
needs well-reasoned and vocal assistance from the medical,
bioethics and religious communities as well as the public at large.
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Ethical and Legal
Ramifications of
Predictive Genetic
Information
Manuel Aranda, Jr., JD, MA
Faculty of Religion
Loma Linda University
In 1989, Congress ushered in a new era in genetics by
initiating a study called "The Human Genome Project" (HGP).
Funded by the Department of Energy and the National Institutes of Health, it is the largest biological research effort ever
undertaken. l The HGP is not, however, solely the work of the
United States. It is an international endeavor. The United
Kingdom, France, Germany, Denmark and other European
countries have already entered the race to unravel the mysteries
of the human genome. 2
In the United States, the $3 billion Genome Project (approximately $200 million per year for 15 years) rivals the Manhattan
Project and the Apollo moon landing program in scope. 3
The HGP will not only give biologists and physicians direct
computer access to the secrets of our chromosomes, but will also
provide ethicists and lawyers enough material to ponder the
ethical and legal ramifications of humanity's tinkering with the
human genome. 4
Perhaps the most important area of the H GP research will be
the identification of genes that predispose individuals to disease.
Already, genetic researchers have taken the first step of many
steps necessary for the elimination of nearly 4,000 diseases that
have plagued the human race for centuries. s As of 1991, the
chromosomal location of 500 genetic disorders had been determined. 6 The genes responsible for Cystic Fibrosis, Duchenne
Muscular Dystrophy, Marfan Syndrome, Fragile X-Syndrome,
and certain cancers have already been identified'?
So rapid are the discoveries taking place that in the past year
scientists have located the genes for Huntington's disease, Lou
Gehrig's Disease, the so-called Bubble-Boy Disease, and a
common kind of colon cancer, among others. 8
However, in the aftermath of these momentous scientific
discoveries lies a sobering price to be paid by all of us. Genetic
predisposition to deadly diseases is, perhaps, the most ernotionladen medical information that a person can have. To learn that
one has a predisposition to cancer, Alzheimer's Disease, SickleCell Anemia, Huntington's Disease while one is asymptomatic
can be overwhelming.
As the amount of detailed predictive genetic information
grows, medical scientists, physicians, and lawyers will be required
to re-examine basic ethical principles of patient autonomy,
informed consent, right of privacy, confidentiality, and justice.
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Putting aside provocative challenges confronted by the manipulation of human genotypes and phenotypes, research on the
uman genome will generate ethical and legal questions pertaining to the use and dissemination of genetic information
affecting individuals. Consider the following:
If genetic testing reveals that an individual is carrying a
defective gene that can result in a drastic change of his or her lifestyle and of the quality of his or her life, who, other than the
patient, has the right to know of the genetic makeup? What use
may be made of this knowledge?
Genetic information is valuable not only to the patient, but
to employers, insurers, educational institutions, law enforcement agencies, and others who wish to gain access to an
individual's personal genetic profile. 9 "A drop of blood, a lock of
hair," a scraping of skin contains all the genetic information
needed to determine whether someone is at risk of contracting
a crippling disease or whether the accused is the perpetrator of
the alleged crime. 10 As genetic information accumulates, many
people may find themselves stigmatized as bad risks for insurance and for employment because they are carriers of a deadly
disease. Can employers and insurers demand its disclosure as a
condition of employment or of receiving insurance coverage?11
In criminal trials, will juries be technically prepared to accept
genetic information that can go conclusively to the guilt or
innocence of the defendant?12
In addition, in some quarters there is the concern that the use
of genetic information can involve the possibility of racial, ethnic
or gender discrimination in employment practices and in health
and life insurance coverage. 13
Should we add laws against discrimination on grounds of
genetic makeup to those against discrimination on grounds of
race, religion, and gender?14
While ethicists and lawyers may clash over the answers to
these questions, even to the form of the question, in a larger
sense, society itself will have to respond to rapid accumulation of
predictive genetic information.
How will society respond to and control the use of specific,
detailed genetic information when such information can directly
affect yet unborn children, even not-yet-conceived children?
Scientists have already developed highly reliable tests for the
detection of the gene associated with the Fragile X-Syndrome.
Consequently, mentally normal men and women who carry a
"silent" version of the gene that can lead to retardation in
children or grandchildren can be identified. Is
How will society respond to the use of specific and detailed
genetic information when scientists uncover the gene( s) involving
antisocial behavior and mental distress?16 How will society
control the dissemination of genetic information when such
information links homosexuality and alcoholism to genetic
makeup?17 Failure to safeguard the confidentiality of such
information could affect a person's employment, insurability,
and privacy.
With these questions in mind, and with no answers in hand,
a list of the major ethical issues that ought to govern the attitudes
and actions of genetic researchers, physicians, genetic counselors, and lawyers is presented.
Autonomy. Preeminent in the principle of autonomy is the
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idea of respect. To respect a person's autonomy means to
recognize that every person has the right of self-determination,
the right to make his own decisions about the life he or she is to
live and how he or she is to live it. Respect means not to interfere,
usurp or limit the individual's choices or beliefs, even if we may
believe his or her choice or belief is wrong or foolish.
In the arena ofgenetic information, respect for the individual's
autonomy means that the patient ought to have the final word as
to the use and dissemination of genetic information that affects
his or her life or death.
Securely grounded to the principle of autonomy is the
principle of confidentiality. New genetic discoveries pertaining
to gene-caused diseases will result in genetic screening and
testing that will uncover a great deal of predictive genetic
information. A patient may want such information to be kept
confidential. I8

Should we add laws against
discrimination on grounds of
genetic makeup to those against
discrimination on grounds of
race, religion, andgender.~
Ought the physician breach the confidentiality relationship in
order to pass on "genetic news" to the immediate family? Or,
should he maintain that relationship even though harm to third
parties may be certain, but in the distant future? Is harm to third
parties the ethical justification for the breach of a confidential
relationship?
Non-maleficence is the duty to minimize or prevent the infliction of harm on an individual or on families. Since Hippocrates
wrote the words, "I will abstain from all wrong-doing and harm,"
the medical profession has taken these words and fashioned
them into a practical medical ethic, Primum non tlOCere, "Above
all, do no harm." Revelation of genetic information to the patient
when it is not wanted or dissemination of "genetic news" to third
parties can cause serious psychological and emotional harm.
"Experience has shown that the process of explaining genetic
risks is complex; understanding comes slowly and painfully.
The psychological burdens of genetic disease can be massive
and not everyone wants to know his or her own risk." 19 Can harm
to the patient be avoided?
Beneficence, in the context of dissemination of genetic information, requires the physician or genetic counselor to abstain
from harming others and to take positive steps to assist others to
further their interests largely by removing or preventing possi ble
harm.20 How is beneficence manifested when one is dealing
with rare diseases that in an earlier time might have been
explained as a manifestation of fate or of God's judgment, and
now must be explained in terms of genetic makeup? How can
present harm be avoided and the future interest of a family

5

protected by informing a person that his or her presently
asymptomatic children may develop a deadly disease?
Informed Consent. If a person is to make decisions about his or
her life and family, those decisions ought to be informed. A
person's autonomy is respected when enough information is
given as to what genetic testing will reveal and how that information may affect family, employment, insurance coverage and
future health. With such information the patient will be able to
make an informed decision to accept or reject genetic testing.
Justice. The concept of justice informs us that similar people
in similar circumstances ought to be treated similarly. But,
therein is the rub. If an individual has been tested and found to
be a carrier of a defective gene that will later result in a crippling
disease, and, commensurate therewith, enormous medical costs,
will that information consign him or her to a "biological
underclass?"21 In matters of employment, education and insurance will he or she be treated the same as the person who
refuses genetic testing?
The discoveries of medical scientists will increase our understanding of the relationshi p between a person's genetic traits and
his or her future health risks and, hopefully, increase our awareness of the ethical ramifications of predictive information.
In the end, the success of scientific discoveries by HGP
researchers will be measured not only by their alleviations of
human suffering but by their uncompromising willingness to
maintain moral imperatives. There must be ethical limits to the
search for knowledge.
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MA Program

(continuedfrom page 8)

Students are required to complete 48 quarter units
including the required courses listed below.
RELE 504 Research Methods (4)
Presuppositions and procedures for research in the
humanities and sciences pertinent to specialists in ethics;
the use of libraries as research centers; advanced methods
of expository and persuasive writing; ways and means of
preparing and presenting term papers, theses, and scholarly
articles.

FACULTY
LEIGH BISHOP, MD, MA
University of Texas, Galveston, 1980
University of California, Riverside, 1992
Associate Professor of Psychiatry and Medical Philosophy

DAVID R. LARSON, OM in, PhD
School of Theology at Claremont, 1973
Claremont Graduate School, 1982
Program Coordinator
Professor of Christian Ethics
Co-Director, Center for Christian Bioethics

ROBERT D. ORR, MD

RELE 524 Christian Bioethics (4)
A discussion of current bioethical controversies such as
abortion, euthanasia, allocating scarce medical resources,
mind and behavior control, and artificial methods of human
procreation. Analysis of a variety of Christian and nonChristian interpretations of these and related issues. Alternative understandings of Christianity's distinctive contributions to bioethical inquiry.
RELE 548 Christian Social Ethics (4)
An in-depth opportunity for the graduate students to
discover the implications of Christian belief for selected
'problems in social ethical theory and practice.

RELE 554 Clinical Intensive in Biomedical Ethics (4)
An intensive study of the theories and applications of
clinical biomedical ethics. Discussion of classic and current
case studies in the field. Supervised participation in ethics
consultation in acute care medical centers.
RELE 555 Clinical Intensive in Biomedical Ethics (4)
Continuation of RELE 554

McGill University, 1966
Associate Professor of Family Medicine
Director of Clinical Ethics, LLUMC
Co-Director, Center for Christian Bioethics

JACK W. PROVONSHA, MD, PhD
Lorna Linda University, 1953
Claremont Graduate School, 1967
Emeritus Professor of Philosophy of Religion and Christian Ethics

JAMES W. WALTERS, PhD
Claremont Graduate School, 1979
Professor of Christian Ethics

GERALD R. WINSLOW, PhD
Graduate Theological Union, 1979
Dean, Faculty of Religion
Professor of Christian Ethics

ASSOCIATE FACULTY
ROY BRANSON, PhD
Harvard University, 1968
Adjunct Professor of Christian Ethics

CHARLES W. TEEL, Jr., PhD

RELE 577 Theological Ethics (4)
Ethical dimensions of theological positions advocated
in the twentieth century.
RELE 588 Types of Ethical Theory (4)
A critical analysis of basic theories propounded in philosophical ethics and their relevance to bioethical decisionmaking. A study of the writings of major ethical theorists,
including Plato, Aristotle, Immanuel Kant, and}. S. Mill. A
consideration of philosophical ethics as compared with the
Christian faith.

Boston University, 1972
Adjunct Professor of Christian Ethics

LOIS VAN CLEVE, PhD
Claremont Graduate School, 1985
Professor of Nursing

CLINICAL FACULTY
DENNIS DeLEON, MD
University of Tennessee, Memphis, 1989
Assistant Professor of Family Medicine
Clinical Ethics, LLUMC

,ELE 697 Independent Research (8) plus

STEVEN B. HARDIN, MD

RELE 698 Thesis (4) or Approved electives (12)

Lorna Linda University, 1985
Assistant Professor of Medicine
Clinical Ethics
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GRADUATE PROGRAM COMBINES
BIOMEDICAL AND CLINICAL ETHICS
The Graduate School at Lorna Linda University offers
an interdisciplinary program leading to a Master of Arts
degree in Biomedical and Clinical Ethics. This program
allows students to explore historic traditions of ethical
thought, gain clinical experience in the medical setting,
and develop critical skills for applying theory and values to
contemporary moral and social issues.
The program in Biomedical and Clinical Ethics is especially valuable for those preparing for careers as hospital
chaplains, clinical ethicists, nurses, physicians, and other
health-care professions. It is specifically designed for two
types of students: (1) those who are pursuing this degree in
order to enhance their existing careers in related fields, and
(2) those who are pursuing this degree as a stepping stone
to a doctorate in philosophy, theology, ethics, medicine,
nursing, law, or other related fields. The MA in Biomedical
and Clinical Ethics is an excellent opportunity to balance a

To request further information and applications for the
MA program in Clinical and Biomedical Ethics, write:
Office of the Dean
Graduate School
Lorna Linda University
Lorna Linda, California 92350-0001
FAX (909) 824-4859
Phone (909) 824-4529

8
CENTER FOR CHRISTIAN BIOETHICS
Lorna Linda University
Lorna Linda, CA 92350

theoretical understanding of ethics with practical application in the clinical setting.
The faculty for this program is committed to exploring
ethical issues in medicine and related fields from Christian
perspectives. Students come from a variety of religious and
cultural backgrounds. A mutual and shared respect for
various cultures and beliefs is emphasized on the campus
and in the classroom.
The faculty offering courses in biomedical and clinical
ethics is composed of scholars in Biblical and religious
studies, bioethics, sociology of religion and ethical theory.
F our members of the faculty are physicians with training
and professional experience in clinical ethics. This concentration of diverse specialists provides the MA student
with a rich opportunity to benefit from a variety of approaches to the fields of biomedical and clinical ethics
resulting in a balanced program of study.
The Center for Christian Bioethics at Lorna Linda
University provides opportunities for students to participate in the workings of an active ethics institute. The
Center for Christian Bioethics also possesses an extensive
bioethics library. The Center sponsors monthly Ethics
Grand Rounds featuring guest speakers and current issues
in medicine and ethics. As a premier teaching and research
hospital, Lorna Linda University lV1edicai Center is an
excellent setting for the clinical aspects of this program.
(Continued on page 7)
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